BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4806747)

  • 1. [Action of orciprenaline administrated orally in threatened abortion].
    Uranga Imaz FA; Goñi JA; Selva A
    Obstet Ginecol Lat Am; 1973; 31(9-10):352-8. PubMed ID: 4806747
    [No Abstract]   [Full Text] [Related]  

  • 2. [Action of orciprenaline as an inhibitor of uterine contractions in threatened premature labor. Secondary effects on the maternal cardiovascular system and on the fetal heart rhythm. Clinical contribution].
    Scarpa F; Vucusa C
    Minerva Ginecol; 1976 Jan; 28(1):69-86. PubMed ID: 1256708
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical results of treatment with orciprenaline of threatened abortion of premature labor. Use of Alupent in obstetrics].
    Conte D; Cisotto F
    Minerva Ginecol; 1972 Apr; 24(6):309-19. PubMed ID: 4671739
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of threatened early abortion (6th-16th week of pregnancy) of Th 1165a (Partusisten)].
    Bärmig H; Krzoska C
    Zentralbl Gynakol; 1976; 98(13):792-4. PubMed ID: 8935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Control of uterine contraction with tocolytic agents (ritodrine). 2. Use in cases of threatened abortion, cervical incontinence and gynecologic surgery in pregnancy].
    Colombo PA; Pittino R; Pascalino MC; Quaranta S
    Ann Ostet Ginecol Med Perinat; 1981; 102(6):431-40. PubMed ID: 7337350
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of early threatened abortion (6th-16th week of pregnancy) using a new tocolytic agent (Th 1165a)].
    Bärmig H; Krzoska C
    Zentralbl Gynakol; 1974 Jan; 96(2):55-8. PubMed ID: 4606038
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy.
    Palagiano A; Bulletti C; Pace MC; DE Ziegler D; Cicinelli E; Izzo A
    Ann N Y Acad Sci; 2004 Dec; 1034():200-10. PubMed ID: 15731312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of orciprenaline on uterine contractility and maternal heart rate. A quantitative study.
    Belizan JM; Diaz AG; Abusleme C; Poseiro JJ; Caldeyro-Barcia R
    Obstet Gynecol; 1975 Oct; 46(4):385-8. PubMed ID: 1165871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Control of the effect of treatment in late threatened abortions using the DU-1 Dynamo-uterograph].
    Tsenov D; Penev I; Tsankov Ts
    Akush Ginekol (Sofiia); 1982; 21(1):11-5. PubMed ID: 7081613
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of Alupent in obstetrics. Our personal experiences].
    Di Terlizzi G
    Minerva Ginecol; 1973 Apr; 25(4):225-45. PubMed ID: 4710133
    [No Abstract]   [Full Text] [Related]  

  • 11. [Magnesium sulfate treatment of threatened late abortions and premature labor].
    Penev I; Pavlova F; Naumov I; Shtereva K; Vlasova D
    Akush Ginekol (Sofiia); 1981; 20(4):265-8. PubMed ID: 7304843
    [No Abstract]   [Full Text] [Related]  

  • 12. [Characteristics of the course and management of pregnancy in placenta praevia].
    Sidorova IS; Botvin MA; Khachapuridze VV
    Sov Med; 1989; (6):108-11. PubMed ID: 2799480
    [No Abstract]   [Full Text] [Related]  

  • 13. [The use of ritodrine in obstetrics].
    Bompiani A; Liverani A; Romanini C
    Ann Ostet Ginecol Med Perinat; 1980; 101(1):5-31. PubMed ID: 6994568
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of premature labor by tocolysis].
    Kölblová V
    Cesk Gynekol; 1977 May; 42(4):302-3. PubMed ID: 862067
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of clofelin on uterine contractile activity (experimental and clinical research)].
    Khushvakhtova EKh; Arzhanova NO; Zaĭtseva AA
    Eksp Klin Farmakol; 1992; 55(4):23-4. PubMed ID: 1458180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of intra-partum fetal distress. I. Use of beta-mimetic drugs. Orciprenaline].
    Vargas García C; Lowenberg E
    Ginecol Obstet Mex; 1980 Oct; 48(288):231-45. PubMed ID: 7215898
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study of the inhibitory action of beta-adreno-mimetic drugs on the uterus].
    Guevara Rubio G; Urzúa Leos MA; Armas Domínguez J; Karchmer S
    Ginecol Obstet Mex; 1976 Nov; 40(241):363-9. PubMed ID: 795730
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinico-experimental studies on the use of orciprenaline in labor].
    Sani G; Belvederi GD; Facchini V; La Marca S
    Minerva Ginecol; 1975 Aug; 27(8):638-47. PubMed ID: 1221323
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the effects of chlormadinone in the treatment of threatened abortion].
    Cárdenas J
    Ginecol Obstet Mex; 1973 Jan; 33(195):121-4. PubMed ID: 4121383
    [No Abstract]   [Full Text] [Related]  

  • 20. [Persistent pulmonary hypertension in the newborn caused by prenatal use of prostaglandin inhibitors, (indomethacin). Report of a case].
    Lozano González CH; Galindo Jiménez P; Pezzotti MA; Lowenberg Favela E
    Ginecol Obstet Mex; 1980 Aug; 48(286):103-10. PubMed ID: 7450523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.